1026747-16-9 Usage
Description
1-(5-amino-2-methylphenyl)-3-[3-oxo-3-(3-pyridinyl)-1-prop-1-enyl]guanidine is a complex organic compound characterized by its unique molecular structure. It features a guanidine group, an amino group, a phenyl group, and additionally incorporates a propenyl and pyridinyl functional group. 1-(5-amino-2-methylphenyl)-3-[3-oxo-3-(3-pyridinyl)-1-prop-1-enyl]guanidine holds promise as a therapeutic agent, given its potential antiviral and antibacterial properties. Its distinctive chemical composition also positions it as a candidate for drug development and pharmaceutical research, although further investigation is necessary to fully comprehend its properties and possible applications.
Uses
Used in Pharmaceutical Research:
1-(5-amino-2-methylphenyl)-3-[3-oxo-3-(3-pyridinyl)-1-prop-1-enyl]guanidine is used as a potential therapeutic agent for its possible antiviral and antibacterial properties, making it a candidate for pharmaceutical research aimed at developing new treatments for various diseases.
Used in Drug Development:
In the field of drug development, 1-(5-amino-2-methylphenyl)-3-[3-oxo-3-(3-pyridinyl)-1-prop-1-enyl]guanidine is utilized as a compound with potential applications in creating new drugs, given its unique chemical structure and pharmacological effects that require further exploration and understanding.
Check Digit Verification of cas no
The CAS Registry Mumber 1026747-16-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,6,7,4 and 7 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1026747-16:
(9*1)+(8*0)+(7*2)+(6*6)+(5*7)+(4*4)+(3*7)+(2*1)+(1*6)=139
139 % 10 = 9
So 1026747-16-9 is a valid CAS Registry Number.
1026747-16-9Relevant articles and documents
PROCESS FOR THE PREPARATION OF IMATINIB AND INTERMEDIATES THEREOF
-
Page/Page column 9, (2010/04/23)
It is the object of the present invention a process for the preparation of 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine and analogues thereof, intermediates useful for the synthesis of Imatinib, or 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide.
